Sort
261,768 grants matching “gene therapy”
University of Texas PDX Development and Trial Center
$1,447,508Jack Roth · University Of Tx Md Anderson Can Ctr · U54 · FY2019 · CA
Preclinical Toxicity Evaluation of a Potent Oncolytic Virus
$1,447,337E. Antonio Chiocca · Ohio State University · U01 · FY2010 · NS
Preclinical Toxicity Evaluation of a Potent Oncolytic Virus
$1,447,337E. Antonio Chiocca · Ohio State University · U01 · FY2010 · NS
Repurposing Gram-positive Antibiotics for Gram-Negative Bacteria using Antibiotic Adjuvants
$1,447,329Christian C Melander · University Of Notre Dame · R01 · FY2025 · AI
Dichlorphenamide vs Acetazolamide for Periodic Paralysis
$1,447,323University Of Rochester · R01 · FY2004 · NS
SLE Treatment with N-acetylcysteine
$1,447,294Andras Perl · Upstate Medical University · U01 · FY2023 · AR
OPTimIzing engageMent in discovery of molecular evolution of low grade glioma (OPTIMUM)
$1,447,257Elizabeth B. Claus · Yale University · U2C · FY2023 · CA
Citalopram Treatment for Agitation in Alzheimer Dementia
$1,446,942Constantine G Lyketsos · Johns Hopkins University · R01 · FY2009 · AG
National Cooperative Program for Infertility Research
$1,446,612University Of Pennsylvania · U54 · FY2004 · HD
GENE REPLACEMENT THERAPY IN HEMATOPOIETIC STEM CELLS
$1,446,593Indiana Univ-Purdue Univ At Indianapolis · P01 · FY2001 · HL
GENETIC DETERMINANTS OF BARRETT'S ESOPHAGUS AND ESOPHAGEAL ADENOCARCINOMA
$1,446,550Amitabh Chak · Case Western Reserve University · U54 · FY2015 · CA
Studies of Tumor-Penetrating Microparticles for Pancreatic Cancer
$1,446,525Elizabeth Ottinger · National Center For Advancing Translational Sciences · ZIA · FY2023 · TR
Profiling the human gut microbiome for potential analgesic bacterial therapies
$1,446,416Philip Peter Strandwitz · Holobiome, Inc. · R34 · FY2021 · NS
Studies of genetic and metabolic disorders, autism and premature aging
$1,446,354Owen Rennert · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2013 · HD
SARS-CoV-2-reactive tissue-resident memory T cells in healthy and cancer subjects
$1,446,305Pandurangan Vijayanand · La Jolla Institute For Immunology · U01 · FY2020 · CA
Role of Innate Immune System in Pathogen Induced Chronic Inflammation
$1,446,237Caroline A Genco · Boston University Medical Campus · P01 · FY2012 · AI
CAR T cell targeting of human islets
$1,446,086Seung K Kim · Stanford University · UC4 · FY2017 · DK
Biochemical mechanisms cyclin-dependent kinases use to control cell division
$1,445,957Mardo Koivomagi · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA
Molecular diagnosis and outcome prediction in lymphoma
$1,445,697Louis Staudt · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA
Clinical development of mechanism-based lymphoma therapies
$1,445,697Louis Staudt · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA
Oncogenic mechanisms and molecular targets in lymphoma
$1,445,697Louis Staudt · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA
Functional genomic screens for molecular targets in cancer
$1,445,697Louis Staudt · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA
Molecular Targets for Drug and Radiation Sensitivity
$1,445,623University Of Pennsylvania · P01 · FY2003 · CA
EXERCISE TRAIL
$1,445,276Laura D. Baker · University Of California, San Diego · U19 · FY2015 · AG
Racial/Ethnic Disparities in Ovarian Cancer Treatment and Survival: An Integrative Approach
$1,445,236Jennifer A. Doherty · University Of Utah · R01 · FY2022 · CA